North Carolina State College of Veterinary Medicine is recruiting patients with canine osteosarcoma to conduct a new study called “The Impact of Palladia on Canine Osteosarcoma.” Palladia, manufactured by Pfizer Animal Health specifically for dogs and approved by the FDA early in 2010, has been used to treat canine mast cell tumors.
If you feel your dog may be a candidate for this study and for further information, please contact: http://ncsu.cvm.edu/cancercare.
Related articles:
Facebook Comments Box
